New Drug For T315I Mutation Which Causes Gleevec Resistance
- From: rob-nospam@xxxxxxxxxxx
- Date: 27 Jul 2005 00:06:48 -0700
New Drug For T315I Mutation Which Causes Gleevec Resistance
Ambit Biosciences has announced the discovery of a new drug that may
work on the T315I
mutation which causes Gleevec resistance in CML patients. This may
become another
important new drug in the CML pipeline.
http://cmlhope.com/?q=node/72
.
- Prev by Date: Re: rats
- Next by Date: Oxygen Uptake Increase?
- Previous by thread: "Brain parasite" case
- Next by thread: Study: Americans pay more for health care, get less
- Index(es):
Relevant Pages
|
|
